Shares of Aarti Drugs and Orbit Exports will remain in focus on Wednesday, as they turn ex-date for the proposed buyback. Aarti Drugs will buy back up to 2.75 lakh shares, representing up to 1.15 per cent stake of the paid-up capital, at ₹875 a share; Orbit Exports’ buy-back of up to 4.44 lakh shares (representing 1.55 per cent stake) would be at a price of ₹180 a share. Both the buyback offers would be on proportionate basis, through the tender offer route.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.